Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorFRAGA, Raquel Scherer de
dc.contributor.authorVAISBERG, Victor Van
dc.contributor.authorMENDES, Luiz Claudio Alfaia
dc.contributor.authorCARRILHO, Flair Jose
dc.contributor.authorONO, Suzane Kioko
dc.date.accessioned2020-06-01T14:52:45Z
dc.date.available2020-06-01T14:52:45Z
dc.date.issued2020
dc.description.abstractNucleos(t)ide analogues (NAs) are the main drug category used in chronic hepatitis B (CHB) treatment. Despite the fact that NAs have a favourable safety profile, undesired adverse events (AEs) may occur during the treatment of CHB. Given the eminent number of patients currently receiving NAs, even a small risk of any of these toxicities can represent a major medical issue. The main objective of this review was to analyse information available on AEs associated with the use of NAs in published studies. We choose the following MesH terms for this systematic review: chronic hepatitis B, side effects and treatment. All articles published from 1 January 1990 up to 19 February 2018 in MEDLINE of PubMed, EMBASE, the Cochrane Library and LILACS databases were searched. A total of 120 articles were selected for analysis, comprising 6419 patients treated with lamivudine (LAM), 5947 with entecavir (ETV), 3566 with tenofovir disoproxil fumarate (TDF), 3096 with telbivudine (LdT), 1178 with adefovir dipivoxil (ADV) and 876 with tenofovir alafenamide (TAF). The most common AEs in all NAs assessed were abdominal pain/discomfort, nasopharyngitis/upper respiratory tract infections, fatigue, and headache. TAF displays the highest density of AEs per patient treated among NAs (1.14 AE/treated patient). In conclusion, treatment of CHB with NAs is safe, with a low incidence of AEs. Despite the general understanding TAF being safer than TDF, the number of patients treated with TAF still is too small in comparison to other NAs to consolidate an accurate safety profile. PROSPERO Registration No. CRD42018086471eng
dc.description.indexMEDLINEeng
dc.description.sponsorshipBrazilian Council for Development of Science and Technology (CNPq)National Council for Scientific and Technological Development (CNPq) [PQ 308609/2018-2]
dc.identifier.citationJOURNAL OF GASTROENTEROLOGY, v.55, n.5, p.496-514, 2020
dc.identifier.doi10.1007/s00535-020-01680-0
dc.identifier.eissn1435-5922
dc.identifier.issn0944-1174
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/35962
dc.language.isoeng
dc.publisherSPRINGER JAPAN KKeng
dc.relation.ispartofJournal of Gastroenterology
dc.rightsopenAccesseng
dc.rights.holderCopyright SPRINGER JAPAN KKeng
dc.subjectChronic hepatitis Beng
dc.subjectNucleotideeng
dc.subjectnucleoside analogueseng
dc.subjectAdverse eventseng
dc.subject.otherpositive chronic hepatitiseng
dc.subject.othertenofovir disoproxil fumarateeng
dc.subject.otherlong-term efficacyeng
dc.subject.otherpegylated interferon alpha-2aeng
dc.subject.otherextended lamivudine treatmenteng
dc.subject.otheradefovir dipivoxil therapyeng
dc.subject.othersurface-antigen carrierseng
dc.subject.otheroral antiviral therapyeng
dc.subject.otherearly viral kineticseng
dc.subject.otherone-year trialeng
dc.subject.wosGastroenterology & Hepatologyeng
dc.titleAdverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic revieweng
dc.typearticleeng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.citation.scopus28
hcfmusp.contributor.author-fmusphcRAQUEL SCHERER DE FRAGA
hcfmusp.contributor.author-fmusphcVICTOR VAN VAISBERG
hcfmusp.contributor.author-fmusphcLUIS CLAUDIO ALFAIA MENDES
hcfmusp.contributor.author-fmusphcFLAIR JOSE CARRILHO
hcfmusp.contributor.author-fmusphcSUZANE KIOKO ONO
hcfmusp.description.beginpage496
hcfmusp.description.endpage514
hcfmusp.description.issue5
hcfmusp.description.volume55
hcfmusp.origemWOS
hcfmusp.origem.pubmed32185517
hcfmusp.origem.scopus2-s2.0-85082752919
hcfmusp.origem.wosWOS:000520633400001
hcfmusp.publisher.cityTOKYOeng
hcfmusp.publisher.countryJAPANeng
hcfmusp.relation.referenceAgarwal K, 2015, J HEPATOL, V62, P533, DOI 10.1016/j.jhep.2014.10.035eng
hcfmusp.relation.referenceAhn J, 2016, ALIMENT PHARM THER, V43, P134, DOI 10.1111/apt.13440eng
hcfmusp.relation.referenceAhn SS, 2014, CLIN MOL HEPATOL, V20, P261, DOI 10.3350/cmh.2014.20.3.261eng
hcfmusp.relation.referenceAl Ashgar H, 2017, SAUDI J GASTROENTERO, V23, P190, DOI 10.4103/sjg.SJG_541_16eng
hcfmusp.relation.referenceAli HY, 2003, SAUDI MED J, V24, P996eng
hcfmusp.relation.referenceAlsohaibani F, 2015, SAUDI J GASTROENTERO, V21, P295, DOI 10.4103/1319-3767.164189eng
hcfmusp.relation.referenceAn J, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0572-2eng
hcfmusp.relation.referenceBedimo R, 2012, AIDS, V26, P825, DOI 10.1097/QAD.0b013e32835192aeeng
hcfmusp.relation.referenceBerg T, 2014, J HEPATOL, V60, P715, DOI 10.1016/j.jhep.2013.11.024eng
hcfmusp.relation.referenceBerg T, 2010, GASTROENTEROLOGY, V139, P1207, DOI 10.1053/j.gastro.2010.06.053eng
hcfmusp.relation.referenceBooth A, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-2eng
hcfmusp.relation.referenceButi M, 2016, LANCET GASTROENTEROL, V1, P90, DOI [10.1016/S2468-1253(16)30107-8, 10.1016/S2468-1253(16)30020-6]eng
hcfmusp.relation.referenceButi M, 2015, DIGEST DIS SCI, V60, P1457, DOI 10.1007/s10620-014-3486-7eng
hcfmusp.relation.referenceButi M, 2012, EUR J GASTROEN HEPAT, V24, P535, DOI 10.1097/MEG.0b013e3283511287eng
hcfmusp.relation.referenceChan HLY, 2007, ANN INTERN MED, V147, P745, DOI 10.7326/0003-4819-147-11-200712040-00183eng
hcfmusp.relation.referenceChan HLY, 2016, LANCET GASTROENTEROL, V1, P185, DOI 10.1016/S2468-1253(16)30024-3eng
hcfmusp.relation.referenceChan HLY, 2014, GASTROENTEROLOGY, V146, P1240, DOI 10.1053/j.gastro.2014.01.044eng
hcfmusp.relation.referenceChan HLY, 2005, ANN INTERN MED, V142, P240, DOI 10.7326/0003-4819-142-4-200502150-00006eng
hcfmusp.relation.referenceChang TT, 2009, J VIRAL HEPATITIS, V16, P784, DOI 10.1111/j.1365-2893.2009.01142.xeng
hcfmusp.relation.referenceChang TT, 2005, GASTROENTEROLOGY, V129, P1198, DOI 10.1053/j.gastro.2005.06.055eng
hcfmusp.relation.referenceChang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285eng
hcfmusp.relation.referenceChien RN, 2014, J GASTROEN HEPATOL, V29, P185, DOI 10.1111/jgh.12416eng
hcfmusp.relation.referenceDa Silva LC, 2001, J GASTROENTEROL, V36, P476, DOI 10.1007/s005350170071eng
hcfmusp.relation.referencede Man RA, 2001, HEPATOLOGY, V34, P578, DOI 10.1053/jhep.2001.26815eng
hcfmusp.relation.referenceDienstag JL, 2003, HEPATOLOGY, V37, P748, DOI 10.1053/jhep.2003.50117eng
hcfmusp.relation.referenceDIENSTAG JL, 1995, NEW ENGL J MED, V333, P1657, DOI 10.1056/NEJM199512213332501eng
hcfmusp.relation.referenceDienstag JL, 1999, NEW ENGL J MED, V341, P1256, DOI 10.1056/NEJM199910213411702eng
hcfmusp.relation.referenceDienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013eng
hcfmusp.relation.referenceDu Jeong In, 2017, Dig Dis Sci, V62, P2908, DOI 10.1007/s10620-017-4737-1eng
hcfmusp.relation.referenceDu QW, 2013, MED SCI MONITOR, V19, P751, DOI 10.12659/MSM.889443eng
hcfmusp.relation.referenceEuropean Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021eng
hcfmusp.relation.referenceFontana RJ, 2009, HEPATOLOGY, V49, pS185, DOI 10.1002/hep.22885eng
hcfmusp.relation.referenceFung J, 2011, J ANTIMICROB CHEMOTH, V66, P2715, DOI 10.1093/jac/dkr388eng
hcfmusp.relation.referenceFung S, 2017, J HEPATOL, V66, P11, DOI 10.1016/j.jhep.2016.08.008eng
hcfmusp.relation.referenceFung S, 2014, GASTROENTEROLOGY, V146, P980, DOI 10.1053/j.gastro.2013.12.028eng
hcfmusp.relation.referenceGane EJ, 2011, LIVER INT, V31, P676, DOI 10.1111/j.1478-3231.2011.02490.xeng
hcfmusp.relation.referenceGill US, 2015, J INFECT DIS, V211, P374, DOI 10.1093/infdis/jiu471eng
hcfmusp.relation.referenceGilson RJC, 1999, J VIRAL HEPATITIS, V6, P387, DOI 10.1046/j.1365-2893.1999.00182.xeng
hcfmusp.relation.referenceGish RG, 2007, GASTROENTEROLOGY, V133, P1437, DOI 10.1053/j.gastro.2007.08.025eng
hcfmusp.relation.referenceGotham D, 2017, CURR OPIN HIV AIDS, V12, P324, DOI 10.1097/COH.0000000000000379eng
hcfmusp.relation.referenceGuo XH, 2018, INT J ANTIMICROB AG, V52, P201, DOI 10.1016/j.ijantimicag.2018.04.002eng
hcfmusp.relation.referenceGwak GY, 2013, HEPATOL INT, V7, P106, DOI 10.1007/s12072-012-9368-1eng
hcfmusp.relation.referenceHadziyannis SJ, 2000, HEPATOLOGY, V32, P847, DOI 10.1053/jhep.2000.17915eng
hcfmusp.relation.referenceHadziyannis SJ, 2006, GASTROENTEROLOGY, V131, P1743, DOI 10.1053/j.gastro.2006.09.020eng
hcfmusp.relation.referenceHeo J, 2012, ANTIVIR THER, V17, P1563, DOI 10.3851/IMP2277eng
hcfmusp.relation.referenceHill A, 2018, J VIRUS ERAD, V4, P72eng
hcfmusp.relation.referenceHongthanakorn C, 2011, HEPATOLOGY, V53, P1854, DOI 10.1002/hep.24318eng
hcfmusp.relation.referenceHosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180eng
hcfmusp.relation.referenceHou JL, 2015, J VIRAL HEPATITIS, V22, P85, DOI 10.1111/jvh.12313eng
hcfmusp.relation.referenceHou JL, 2013, J VIRAL HEPATITIS, V20, P811, DOI 10.1111/jvh.12115eng
hcfmusp.relation.referenceHou JL, 2015, ADV THER, V32, P727, DOI 10.1007/s12325-015-0232-2eng
hcfmusp.relation.referenceHou JL, 2008, HEPATOLOGY, V47, P447, DOI 10.1002/hep.22075eng
hcfmusp.relation.referenceHuang MX, 2016, CLIN DRUG INVEST, V36, P471, DOI 10.1007/s40261-016-0392-0eng
hcfmusp.relation.referenceHuang MX, 2015, INT J CLIN EXP MED, V8, P666eng
hcfmusp.relation.referenceImaz A, 2017, EXPERT REV ANTI-INFE, V15, P195, DOI 10.1080/14787210.2017.1286736eng
hcfmusp.relation.referenceJia HY, 2015, ANN HEPATOL, V14, P175, DOI 10.1016/S1665-2681(19)30779-3eng
hcfmusp.relation.referenceJia JD, 2014, HEPATOL INT, V8, P72, DOI 10.1007/s12072-013-9488-2eng
hcfmusp.relation.referenceKamezaki H, 2011, SCAND J GASTROENTERO, V46, P1111, DOI 10.3109/00365521.2011.584898eng
hcfmusp.relation.referenceKarino Y, 2010, HEPATOL INT, V4, P414, DOI 10.1007/s12072-009-9162-xeng
hcfmusp.relation.referenceKayaaslan B, 2017, WORLD J HEPATOL, V9, P227, DOI 10.4254/wjh.v9.i5.227eng
hcfmusp.relation.referenceKim HR, 2015, LIVER INT, V35, P860, DOI 10.1111/liv.12605eng
hcfmusp.relation.referenceKim HJ, 2010, J GASTROEN HEPATOL, V25, P1374, DOI 10.1111/j.1440-1746.2010.06381.xeng
hcfmusp.relation.referenceKim HJ, 2010, LIVER INT, V30, P834, DOI 10.1111/j.1478-3231.2010.02245.xeng
hcfmusp.relation.referenceKim HJ, 2015, KOREAN J INTERN MED, V30, P32, DOI 10.3904/kjim.2015.30.1.32eng
hcfmusp.relation.referenceKobashi H, 2009, J GASTROEN HEPATOL, V24, P255, DOI 10.1111/j.1440-1746.2008.05593.xeng
hcfmusp.relation.referenceKoike K, 2018, HEPATOL RES, V48, P59, DOI 10.1111/hepr.12902eng
hcfmusp.relation.referenceKwon YJ, 2015, NIGER J CLIN PRACT, V18, P796, DOI 10.4103/1119-3077.163296eng
hcfmusp.relation.referenceLai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422eng
hcfmusp.relation.referenceLai CL, 2014, GUT, V63, P996, DOI 10.1136/gutjnl-2013-305138eng
hcfmusp.relation.referenceLai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201eng
hcfmusp.relation.referenceLai CL, 2002, GASTROENTEROLOGY, V123, P1831, DOI 10.1053/gast.2002.37058eng
hcfmusp.relation.referenceLai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287eng
hcfmusp.relation.referenceLai CL, 2005, GASTROENTEROLOGY, V129, P528, DOI [10.1053/j.gastro.2005.05.053, 10.1016/j.gastro.2005.05.053]eng
hcfmusp.relation.referenceLai CL, 2002, J MED VIROL, V67, P334, DOI 10.1002/jmv.10075eng
hcfmusp.relation.referenceLai CL, 1997, HEPATOLOGY, V25, P241, DOI 10.1002/hep.510250144eng
hcfmusp.relation.referenceLau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470eng
hcfmusp.relation.referenceLee KS, 2017, CLIN MOL HEPATOL, V23, P331, DOI 10.3350/cmh.2016.0040eng
hcfmusp.relation.referenceLeung NWY, 2014, INFECT DIS THER, V3, P191, DOI 10.1007/s40121-014-0039-5eng
hcfmusp.relation.referenceLeung NWY, 2001, HEPATOLOGY, V33, P1527, DOI 10.1053/jhep.2001.25084eng
hcfmusp.relation.referenceLi XJ, 2013, CLIN THER, V35, P1546, DOI 10.1016/j.clinthera.2013.07.431eng
hcfmusp.relation.referenceLi Y, 2013, J VIRAL HEPATITIS, V20, P46, DOI 10.1111/jvh.12063eng
hcfmusp.relation.referenceLian JS, 2013, WORLD J GASTROENTERO, V19, P6278, DOI 10.3748/wjg.v19.i37.6278eng
hcfmusp.relation.referenceLiaw YF, 2000, GASTROENTEROLOGY, V119, P172, DOI 10.1053/gast.2000.8559eng
hcfmusp.relation.referenceLiaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364eng
hcfmusp.relation.referenceLiaw YF, 2009, GASTROENTEROLOGY, V136, P486, DOI 10.1053/j.gastro.2008.10.026eng
hcfmusp.relation.referenceLim SG, 2007, ALIMENT PHARM THERAP, V26, P1419, DOI 10.1111/j.1365-2036.2007.03506.xeng
hcfmusp.relation.referenceLim YS, 2016, GUT, V65, P1042, DOI 10.1136/gutjnl-2014-308435eng
hcfmusp.relation.referenceLo AOS, 2014, EXPERT REV GASTROENT, V8, P607, DOI 10.1586/17474124.2014.909724eng
hcfmusp.relation.referenceLok AS, 2012, GASTROENTEROLOGY, V143, P619, DOI 10.1053/j.gastro.2012.05.037eng
hcfmusp.relation.referenceLok ASF, 2016, HEPATOLOGY, V63, P284, DOI 10.1002/hep.28280eng
hcfmusp.relation.referenceLok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190eng
hcfmusp.relation.referenceLu DTY, 2000, HEPATOLOGY, V32, P828, DOI 10.1053/jhep.2000.17912eng
hcfmusp.relation.referenceLu JJ, 2013, J VIRAL HEPATITIS, V20, P40, DOI 10.1111/jvh.12062eng
hcfmusp.relation.referenceLuo J, 2013, INT J MED SCI, V10, P427, DOI 10.7150/ijms.5472eng
hcfmusp.relation.referenceLuo XD, 2017, J VIRAL HEPATITIS, V24, P36, DOI 10.1111/jvh.12790eng
hcfmusp.relation.referenceMak LY, 2016, EXPERT OPIN DRUG SAF, V15, P383, DOI 10.1517/14740338.2016.1139573eng
hcfmusp.relation.referenceMarcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431eng
hcfmusp.relation.referenceMarcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681eng
hcfmusp.relation.referenceMarcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878eng
hcfmusp.relation.referenceMarcellin P, 2008, HEPATOLOGY, V48, P750, DOI 10.1002/hep.22414eng
hcfmusp.relation.referenceMarcellin P, 2016, DIGEST DIS SCI, V61, P3072, DOI 10.1007/s10620-015-4027-8eng
hcfmusp.relation.referenceMarcellin P, 2016, GASTROENTEROLOGY, V150, P134, DOI 10.1053/j.gastro.2015.09.043eng
hcfmusp.relation.referenceMarcellin P, 2015, J HEPATOL, V62, P41, DOI 10.1016/j.jhep.2014.08.021eng
hcfmusp.relation.referenceMarcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1eng
hcfmusp.relation.referenceMARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743eng
hcfmusp.relation.referenceMascolo A, 2017, PHARMACOL RES, V123, P122, DOI 10.1016/j.phrs.2017.07.005eng
hcfmusp.relation.referenceMazur Wlodzimierz, 2002, Med Sci Monit, V8, pCR257eng
hcfmusp.relation.referenceMoher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007eng
hcfmusp.relation.referenceMontazeri G, 2001, IRAN J MED SCI, V26, P1eng
hcfmusp.relation.referenceNevens F, 1997, GASTROENTEROLOGY, V113, P1258, DOI 10.1053/gast.1997.v113.pm9322520eng
hcfmusp.relation.referenceOzaras R, 2014, EUR J GASTROEN HEPAT, V26, P774, DOI 10.1097/MEG.0000000000000099eng
hcfmusp.relation.referencePan CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089789eng
hcfmusp.relation.referencePatterson SJ, 2011, GUT, V60, P247, DOI 10.1136/gut.2010.223206eng
hcfmusp.relation.referencePerrillo RP, 2011, HEPATOL INT, V5, P654, DOI 10.1007/s12072-010-9228-9eng
hcfmusp.relation.referencePol S, 2012, J VIRAL HEPATITIS, V19, P377, DOI 10.1111/j.1365-2893.2012.01602.xeng
hcfmusp.relation.referenceRapti I, 2007, HEPATOLOGY, V45, P307, DOI 10.1002/hep.21534eng
hcfmusp.relation.referenceRay AS, 2016, ANTIVIR RES, V125, P63, DOI 10.1016/j.antiviral.2015.11.009eng
hcfmusp.relation.referenceRen FY, 2007, WORLD J GASTROENTERO, V13, P4264, DOI 10.3748/wjg.v13.i31.4264eng
hcfmusp.relation.referenceRidruejo E, 2014, WORLD J GASTROENTERO, V20, P7169, DOI 10.3748/wjg.v20.i23.7169eng
hcfmusp.relation.referenceRizzetto M, 2005, J HEPATOL, V42, P173, DOI 10.1016/j.jhep.2004.10.006eng
hcfmusp.relation.referenceRodriguez M, 2017, WORLD J GASTROENTERO, V23, P7459, DOI 10.3748/wjg.v23.i41.7459eng
hcfmusp.relation.referenceRuane PJ, 2013, JAIDS-J ACQ IMM DEF, V63, P449, DOI 10.1097/QAI.0b013e3182965d45eng
hcfmusp.relation.referenceSafadi R, 2011, LIVER INT, V31, P667, DOI 10.1111/j.1478-3231.2010.02360.xeng
hcfmusp.relation.referenceSantantonio T, 2000, J HEPATOL, V32, P300, DOI 10.1016/S0168-8278(00)80076-8eng
hcfmusp.relation.referenceSarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4eng
hcfmusp.relation.referenceSarin SK, 2005, AM J GASTROENTEROL, V100, P2463, DOI 10.1111/j.1572-0241.2005.00247.xeng
hcfmusp.relation.referenceSchiff ER, 2003, J HEPATOL, V38, P818, DOI 10.1016/S0168-8278(03)00076-Xeng
hcfmusp.relation.referenceShen HJ, 2016, CELL PHYSIOL BIOCHEM, V40, P370, DOI 10.1159/000452552eng
hcfmusp.relation.referenceSherman M, 2006, GASTROENTEROLOGY, V130, P2039, DOI 10.1053/j.gastro.2006.04.007eng
hcfmusp.relation.referenceShin SR, 2011, HEPATOL INT, V5, P664, DOI 10.1007/s12072-010-9238-7eng
hcfmusp.relation.referenceShindo M, 2009, HEPATOL INT, V3, P445, DOI 10.1007/s12072-009-9135-0eng
hcfmusp.relation.referenceSuh DJ, 2010, ANTIMICROB AGENTS CH, V54, P1242, DOI 10.1128/AAC.01163-09eng
hcfmusp.relation.referenceSun J, 2014, HEPATOLOGY, V59, P1283, DOI 10.1002/hep.26885eng
hcfmusp.relation.referenceSung JJY, 2008, J HEPATOL, V48, P728, DOI 10.1016/j.jhep.2007.12.026eng
hcfmusp.relation.referenceSuzuki F, 2008, J GASTROEN HEPATOL, V23, P1320, DOI 10.1111/j.1440-1746.2008.05455.xeng
hcfmusp.relation.referenceTada T, 2018, J GASTROENTEROL, V53, P1196, DOI 10.1007/s00535-018-1467-xeng
hcfmusp.relation.referenceTassopoulos NC, 1999, HEPATOLOGY, V29, P889, DOI 10.1002/hep.510290321eng
hcfmusp.relation.referenceTerrault Norah A, 2018, Clin Liver Dis (Hoboken), V12, P33, DOI 10.1002/cld.728eng
hcfmusp.relation.referenceTerrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156eng
hcfmusp.relation.referenceVitoria M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20504eng
hcfmusp.relation.referenceWang JC, 2013, EUR REV MED PHARMACO, V17, P1162eng
hcfmusp.relation.referenceWang LC, 2011, HEPATOL INT, V5, P671, DOI 10.1007/s12072-010-9243-xeng
hcfmusp.relation.referenceWang Z, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-388eng
hcfmusp.relation.referenceWolters LMM, 2001, EUR J GASTROEN HEPAT, V13, P1499, DOI 10.1097/00042737-200112000-00016eng
hcfmusp.relation.referenceWu IT, 2017, CLIN MICROBIOL INFEC, V23, P464, DOI 10.1016/j.cmi.2017.02.001eng
hcfmusp.relation.referenceYang FQ, 2017, WORLD J GASTROENTERO, V23, P306, DOI 10.3748/wjg.v23.i2.306eng
hcfmusp.relation.referenceYao FY, 2000, J HEPATOL, V33, P301, DOI 10.1016/S0168-8278(00)80371-2eng
hcfmusp.relation.referenceYao GB, 2009, J DIG DIS, V10, P131, DOI 10.1111/j.1751-2980.2009.00375.xeng
hcfmusp.relation.referenceYao Guang-Bi, 2004, Hepatobiliary Pancreat Dis Int, V3, P188eng
hcfmusp.relation.referenceYokosuka O, 2010, J HEPATOL, V52, P791, DOI 10.1016/j.jhep.2009.12.036eng
hcfmusp.relation.referenceYuen MF, 2015, J HEPATOL, V62, P526, DOI 10.1016/j.jhep.2014.10.026eng
hcfmusp.relation.referenceYuen MF, 2011, J GASTROEN HEPATOL, V26, P138, DOI 10.1111/j.1440-1746.2010.06545.xeng
hcfmusp.relation.referenceZhang Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.10.024eng
hcfmusp.relation.referenceZheng MH, 2010, CLIN THER, V32, P649, DOI 10.1016/j.clinthera.2010.04.001eng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication44ddf22c-aaef-427a-a5fa-6bcb83324de8
relation.isAuthorOfPublication38c7e06a-8a9e-4a49-a9da-13a377789a3d
relation.isAuthorOfPublicationf07c7e74-63e7-4ada-a6a7-90537211c263
relation.isAuthorOfPublication9221b8d6-ad80-46e5-a56f-fb3b28a8c155
relation.isAuthorOfPublicationf49d7b43-1452-4a2a-b4d0-cd8ee887852f
relation.isAuthorOfPublication.latestForDiscovery44ddf22c-aaef-427a-a5fa-6bcb83324de8
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
art_FRAGA_Adverse_events_of_nucleostide_analogues_for_chronic_hepatitis_2020.PDF
Tamanho:
579.1 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)